NCT03092791 - IPV-102 Safety, Tolerability and Immunogenicity of TAK-195 in Healthy Infants, Toddlers and Adults | Biotech Hunter

Enrollment

340

Participants

Timeline

Start Date

June 7, 2017

Primary Completion Date

April 3, 2018

Study Completion Date

October 18, 2018

Conditions

Poliomyelitis

Interventions

BIOLOGICAL

Sabin-Based Inactivated Poliomyelitis Vaccine (sIPV)

sIPV intramuscular injection

BIOLOGICAL

Reference IPV

Reference IPV intramuscular injection

BIOLOGICAL

sIPV Placebo

sIPV placebo-matching intramuscular injection

Trial Locations (4)

CEVAXIN - David, Chiriquí

CEVAXIN - 24 de Diciembre, Panama City

CEVAXIN - Chorrera, Panama City

CEVAXIN Plaza Carolina - Ciudad de Panama, Panama City